Innovations in Pancreatic Cancer
In this CME, Alessandro Paniccia, MD, Monica Malhotra, MD, Anil Dasyam, MD and Amer Zureikat, MD, discuss innovations in pancreatic cancer.
Upon completion of this activity, participants should be able to:
- Explain knowledge on the limitations and advantages of minimally invasive compared to open pancreaticoduodenectomy
- Identify knowledge of national trends of adoption of robotic and laparoscopic pancreaticoduodenectomy and their respective outcomes
- Follow recommended processes and procedures for safe implementation of a robotic pancreatic program, including importance of learning curve, robotic training curriculum and biotissue practice
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 04/07/2022 | Last Modified On: 04/07/2022 | Expires: 04/07/2023